Wall Street closes higher, Nasdaq sets record as potential vaccines show promise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Futures point to higher open as more earnings roll in
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil falls back after robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Apple, PepsiCo, JetBlue fall premarket; Amazon, GM and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
Morgan Stanley Reiterates Equalweight Rating on Pfizer (PFE) Following COVID Vaccine Update
July 21, 2020 8:42 AM EDTMorgan Stanley analyst David Risinger reiterated an Equalweight rating and $36.00 price target on Pfizer (NYSE: PFE) following the company's COVID vaccine update. Results appear encouraging vs. MRNA and AZN, but x-trial comps are confounded.
Risinger await results from BNT162b2(full spike)... More
Amazon (AMZN) Hovers Near Session High, Up 7%
July 20, 2020 2:55 PM EDTAmazon (NASDAQ: AMZN) Hovers Near Session High, Up 7%
... MoreTesla (TSLA) adds to gains, shares now up 8.2%
July 20, 2020 1:43 PM EDTTesla (NASDAQ: TSLA) adds to gains, shares now up 8.2%
... MoreAmazon (AMZN) Continues to Outperform Major Indexes, Up 4.75% to $3,100
July 20, 2020 11:30 AM EDTAmazon (NASDAQ: AMZN) Continues to Outperform Major Indexes, Up 4.75% to $3,100
Mizuho 'Encouraged' by Pfizer (PFE) COVID-19 Vaccine Data
July 20, 2020 10:57 AM EDTMizuho Securities analyst Vamil Divan reiterated a Buy rating and $38.00 price target on Pfizer (NYSE: PFE), citing continued positive progress on its COVID vaccine.
The analyst commented, "We are encouraged by new data from Pfizer and partner BioNTech on the progress they are... More
Amazon.com (AMZN) PT Raised to $3,350 at MKM Partners
July 20, 2020 8:15 AM EDTMKM Partners analyst Rohit Kulkami raised the price target on Amazon.com (NASDAQ: AMZN) to $3,350.00 (from $2,525.00) while maintaining a Buy rating.
The analyst comments "We are increasing our 2020 and 2021 Revenue & EPS estimates (again). Our 2021 Revenue estimates are now 8% above pre-Covid levels, but... More
